Mode
Text Size
Log in / Sign up
N/A N=14

Accuracy of Owlet Smart Sock Sensor 3rd Generation With Profound Hypoxia

Hypoxia

Enrolled (actual)
14
Serious AEs
0.0%
Results posted
Oct 2020
Primary outcome: Primary: SpO2 Accuracy (Arms) of ≤3 Between 70 and 100% — 2.10; 2.19 Percentage

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Owlet Smart Sock Sensor 3rd Generation (Diagnostic_test)
Age
Adult · 18+ yrs
Sex
All
Sponsor
Owlet Baby Care, Inc.
Primary completion
Mar 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
SpO2 Accuracy (Arms) of ≤3 Between 70 and 100%
2.10; 2.19

Summary

Performance testing of pulse oximeters. The protocol involves brief stable arterial oxygen desaturation in healthy volunteers and sampling arterial blood when a stable level of hypoxia has been attained. The blood sample is analyzed for oxygen saturation with a gold standard bench CO-oximeter. This protocol is aligned with the latest ISO and FDA guidance documents for pulse oximeter testing.

Eligibility Criteria

Inclusion Criteria

  • The subject is male or female, aged ≥18 and 30).
  • The subject has a known history of heart disease, lung disease, kidney or liver disease.
  • Diagnosis of asthma, sleep apnea, or use of CPAP.
  • Subject has diabetes.
  • Subject has a clotting disorder.
  • The subject a hemoglobinopathy or history of anemia, per subject report or the first blood sample, that in the opinion of the investigator, would make them unsuitable for study participation.
  • The subject has any other serious systemic illness.
  • The subject is a current smoker.
  • Any injury, deformity, or abnormality at the sensor sites that in the opinion of the investigators' would interfere with the sensors working correctly.
  • The subject has a history of fainting or vasovagal response.
  • The subject has a history of sensitivity to local anesthesia.
  • The subject has a diagnosis of Raynaud's disease.
  • The subject has unacceptable collateral circulation based on exam by the investigator (Allen's test).
  • The subject is pregnant, lactating or trying to get pregnant.
  • The subject is unable or unwilling to provide informed consent, or is unable or unwilling to comply with study procedures.
  • The subject has any other condition, which in the opinion of the investigators' would make them unsuitable for the study.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04446247). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search